Stryker wins FDA nod for spine guidance software
July 30, 2024
Stryker (NYSE: SYK)+
announced today that it received FDA 510(k) clearance for its Q Guidance System with Spine Guidance 5 software featuring Copilot.
Stryker (NYSE: SYK)+
announced today that it received FDA 510(k) clearance for its Q Guidance System with Spine Guidance 5 software featuring Copilot.
Siemens Healthineers‘ Varian announced that it received FDA 510(k) clearance for its IntelliBlate microwave ablation system.
GentleCath Air for Women with FeelClean Technology protects against urethral damage and the risk of UTIs.
Extension to Indications for Use follows submission of results from a human factors study evaluating the safe and effective use of the device in the home care setting.
The company that brought you no-stick toothpaste is moving into the medical space, with a lubricant for ostomy pouches and other products that could improve millions of lives.
A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.
Corify Care announced today that it received CE mark approval under the new medical device regulation (MDR) for its Acorys cardiac mapping system.
CorVascular announced today that the FDA granted clearance for its VasoGuard V-Series portfolio of devices.
EYSINS, Switzerland, July 29, 2024 /PRNewswire/ — AliveDx (“Company”) is proud to announce it has received IVDR CE mark for its groundbreaking microarray immunoassay, designed for the detection of a specific IgE directed to a protein allergen in human serum. This is the Company’s first product for the evaluation of allergies, enhancing its portfolio of products beyond autoimmunity.
In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving “dancing molecules,” to repair tissues and reverse paralysis after severe spinal cord injuries.